VAERS reports by lot

Pfizer COVID-19 lot FX5095: VAERS reports

120 VAERS reports list lot FX5095 as a Pfizer COVID-19 vaccine, received between 2022-11-03 and 2024-07-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
120
Reports
2%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1624%
Gastrointestinal1522%
Dermatological (non-injection-site)710%
Cardiac / Cardiovascular69%
Respiratory69%
Psychiatric / Neuropsychiatric57%
Neurological46%
Injection-site / Local reaction46%
Thrombotic / Hematological23%
Allergic / Anaphylactic23%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California23
Washington19
Michigan10
Illinois8
Pennsylvania8
Texas7
Colorado5
Wisconsin5
Tennessee5
Vermont3
Ohio3
District of Columbia2

Reports by month received

2022-111
2022-125
2023-0121
2023-0221
2023-0318
2023-0416
2023-052
2023-0611
2023-073
2023-0815
2023-101
2023-114
2024-051
2024-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.